Impact
-
Scarlet raises $50m around medical AI certification
London-based Scarlet has secured a $50 million Series B to expand its certification work for AI-enabled medical devices, where regulatory reviews can lag software releases.
-
NHS data platform trust returns to procurement decisions
England’s National Data Guardian has urged ministers to put public trust, interoperability and evidence at the centre of decisions about the NHS Federated Data Platform.
-
HyLight raises €13m to industrialise inspection airships
French infrastructure technology company HyLight has secured €13 million to expand hydrogen-powered airship inspections and its supporting data analysis software.
-
Sava funding supports unapproved glucose microsensor
London-based Sava has raised $36 million and reached a European distribution agreement with Ascensia. Its glucose microsensor remains investigational, with a pivotal study and regulatory decisions still ahead.
-
Robotics hubs move UK adoption beyond demonstrations
The UK has announced £40 million backing for eight Robotics Adoption Hubs, with advice, demonstrations and workforce training intended to help organisations assess and introduce automation.
-
SpectaCell brings chip-based analysis into drug development
SpectaCell has launched with €6 million to develop cell analysis technology combining semiconductor engineering and life sciences research. Its proposed faster drug-testing workflows still need independent validation.
-
MintNeuro moves brain-interface chips towards production
Imperial spinout MintNeuro has raised $5 million to commercialise semiconductor chips designed for neural devices after securing an earlier multi-year supply agreement with US neurotechnology company Motif.
-
NHS sets out £839m GP software framework
NHS England is preparing an £838.7 million framework excluding VAT for GP patient records, clinical software and research, with an open structure designed to broaden the primary care technology market.
-
Rivercell builds the data before the virtual cell
Paris biotechnology company Rivercell has raised $25 million to generate purpose-built experimental cell data and train an AI model intended to predict how human cells respond to drugs and genetic changes.
-
VoltR turns used lithium cells back into production
French battery company VoltR has secured €22 million to expand remanufacturing capacity sixfold, betting that usable lithium cells can return to production before eventually reaching material recycling.
